# GRK4

## Overview
The GRK4 gene encodes the G protein-coupled receptor kinase 4 (GRK4), a member of the kinase family involved in the regulation of G protein-coupled receptors (GPCRs). GRK4 plays a crucial role in the phosphorylation and desensitization of GPCRs, which are pivotal for cellular signaling and homeostasis. The protein is characterized by a kinase domain and a regulator of G protein signaling (RGS) homology domain, and it exists in four splice variants that exhibit distinct cellular localizations and receptor specificities (Allen2015Structure). GRK4 is expressed in various tissues, including the brain and kidneys, where it influences processes such as neurotransmitter signaling and blood pressure regulation. Its activity and expression are linked to clinical conditions like hypertension, with specific polymorphisms in the GRK4 gene associated with altered receptor function and therapeutic responses (Gildea2010HK2; Zhang2024G).

## Structure
The GRK4 protein, a member of the G-protein-coupled receptor kinase family, exhibits a complex molecular structure. It is primarily composed of a kinase domain and a regulator of G protein signaling (RGS) homology domain. The kinase domain adopts the typical AGC kinase fold, characterized by a bilobal structure with an active conformation involving the DFG motif and key interactions between catalytic residues (Allen2015Structure). The RGS domain includes 12 α-helices forming bundle and terminal subdomains, with specific polymorphisms such as R65L and A142V located within this domain (Allen2015Structure).

GRK4 exists in four splice variants: GRK4α, -β, -γ, and -δ, which differ in cellular localization and receptor specificity. These variants result from alternative splicing, leading to structural differences, such as the loss of certain helices in GRK4β and -δ (Allen2015Structure). The A486V variant of GRK4α, associated with hypertension, shows enhanced autophosphorylation and structural differences in the C-tail, which is crucial for kinase activity (Allen2015Structure).

The protein's quaternary structure is suggested to be monomeric in solution, despite crystallizing as a dimer (Allen2015Structure). Post-translational modifications include phosphorylation at multiple sites, which is essential for its activity (Allen2015Structure).

## Function
GRK4 (G protein-coupled receptor kinase 4) is involved in the phosphorylation of G protein-coupled receptors (GPCRs), a critical process for receptor desensitization and regulation of cellular signaling. In cerebellar Purkinje cells, GRK4 mediates the homologous desensitization of metabotropic glutamate receptor 1 (mGlu1) by phosphorylating the receptor, which prevents overstimulation and ensures proper signal termination. This process is essential for maintaining receptor responsiveness to subsequent stimuli and is crucial for the regulation of calcium signaling in these neurons (Sallese2000The).

GRK4 is also expressed in renal proximal tubule cells, where it regulates dopamine 1 receptor (D1R) signaling. It plays a role in the uncoupling of D1Rs from adenylyl cyclase, affecting sodium transport and blood pressure regulation. This function is significant for maintaining sodium balance and normal blood pressure (Gildea2010HK2).

In addition to its role in active receptor phosphorylation, GRK4, along with GRK5 and GRK6, can phosphorylate inactive GPCRs, enhancing arrestin recruitment and modulating receptor activity even in the absence of agonists. This unique ability distinguishes the GRK4 subfamily from other GRKs and contributes to diverse signaling outcomes (Li2015G).

## Clinical Significance
Mutations and altered expression of the GRK4 gene are significantly associated with hypertension, particularly salt-sensitive hypertension. Variants such as R65L, A142V, and A486V have been linked to essential hypertension across various ethnic populations, although the association is not consistent in all studies, potentially due to demographic differences (Zhang2024G). These variants can lead to impaired sodium excretion and increased blood pressure, contributing to the pathogenesis of hypertension (Rayner2015The). 

GRK4 is involved in the desensitization of dopamine receptors in the kidney, which are crucial for sodium transport. Increased GRK4 activity leads to constitutive desensitization of these receptors, impairing sodium excretion and contributing to hypertension (Rayner2015The). In hypertensive subjects, GRK4 activity is elevated, particularly affecting the D1 receptor, which is involved in sodium balance (Felder2002G). 

Additionally, GRK4 polymorphisms are associated with the response to antihypertensive medications. For example, African-American men with the GRK4 142V variant respond more rapidly to the β1-AR blocker metoprolol, while the presence of GRK4 65L decreases this response (Zhang2024G). These findings highlight the clinical significance of GRK4 in hypertension and its potential as a therapeutic target.

## Interactions
GRK4 interacts with various proteins, playing a significant role in receptor signaling and desensitization. It forms protein complexes with the GABA B receptor (GABA B R) subunits, particularly the GB 2 R subunit. This interaction is crucial for the desensitization of GABA B R signaling. Studies using fluorescence resonance energy transfer (FRET) and coimmunoprecipitation have demonstrated that GRK4 translocates to the plasma membrane upon GABA B R activation and preferentially associates with the GB 2 R subunit (Kanaide2006Desensitization).

GRK4 also interacts with G protein subunits. It has been shown to preferentially bind to inactive forms of Gαs and Gα13 subunits, as well as Gβ subunits, forming a complex that may influence receptor signaling pathways. This interaction is significant because GRK4 is constitutively active and linked to hypertension through its polymorphisms (Keever2008G).

These interactions highlight GRK4's role in modulating receptor activity and cellular responses, impacting physiological processes such as blood pressure regulation and neurotransmitter signaling. The ability of GRK4 to interact with both receptor subunits and G protein subunits underscores its importance in cellular signaling networks.


## References


[1. (Allen2015Structure) Samantha J. Allen, Gopal Parthasarathy, Paul L. Darke, Ronald E. Diehl, Rachael E. Ford, Dawn L. Hall, Scott A. Johnson, John C. Reid, Keith W. Rickert, Jennifer M. Shipman, Stephen M. Soisson, Paul Zuck, Sanjeev K. Munshi, and Kevin J. Lumb. Structure and function of the hypertension variant a486v of g protein-coupled receptor kinase 4. Journal of Biological Chemistry, 290(33):20360–20373, August 2015. URL: http://dx.doi.org/10.1074/jbc.M115.648907, doi:10.1074/jbc.m115.648907. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M115.648907)

[2. (Li2015G) Lingyong Li, Kristoff T. Homan, Sergey A. Vishnivetskiy, Aashish Manglik, John J.G. Tesmer, Vsevolod V. Gurevich, and Eugenia V. Gurevich. G protein-coupled receptor kinases of the grk4 protein subfamily phosphorylate inactive g protein-coupled receptors (gpcrs). Journal of Biological Chemistry, 290(17):10775–10790, April 2015. URL: http://dx.doi.org/10.1074/jbc.m115.644773, doi:10.1074/jbc.m115.644773. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m115.644773)

[3. (Gildea2010HK2) John J. Gildea, Ishan Shah, Ryan Weiss, Nicholas D. Casscells, Helen E. McGrath, Jin Zhang, John E. Jones, and Robin A. Felder. Hk-2 human renal proximal tubule cells as a model for g protein–coupled receptor kinase type 4–mediated dopamine 1 receptor uncoupling. Hypertension, 56(3):505–511, September 2010. URL: http://dx.doi.org/10.1161/hypertensionaha.110.152256, doi:10.1161/hypertensionaha.110.152256. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/hypertensionaha.110.152256)

[4. (Rayner2015The) Brian Rayner and Raj Ramesar. The importance of g protein-coupled receptor kinase 4 (grk4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment. International Journal of Molecular Sciences, 16(3):5741–5749, March 2015. URL: http://dx.doi.org/10.3390/ijms16035741, doi:10.3390/ijms16035741. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms16035741)

[5. (Zhang2024G) Fuwei Zhang, Ines Armando, Pedro A. Jose, Chunyu Zeng, and Jian Yang. G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets. Hypertension Research, 47(9):2317–2336, July 2024. URL: http://dx.doi.org/10.1038/s41440-024-01763-y, doi:10.1038/s41440-024-01763-y. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41440-024-01763-y)

[6. (Keever2008G) Lindsay B. Keever, John E. Jones, and Bradley T. Andresen. G protein-coupled receptor kinase 4γ interacts with inactive gαs and gα13. Biochemical and Biophysical Research Communications, 367(3):649–655, March 2008. URL: http://dx.doi.org/10.1016/j.bbrc.2007.12.181, doi:10.1016/j.bbrc.2007.12.181. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2007.12.181)

[7. (Sallese2000The) Michele Sallese, Lorena Salvatore, Etrusca D’Urbano, Gianluca Sala, Marianna Storto, Thomas Launey, Antonio De Blasi, Ferdinando Nicoletti, and Thomas Knopfel. The g‐protein‐coupled receptor kinase grk4 mediates homologous desensitization of metabotropic glutamate receptor 1. The FASEB Journal, 14(15):2569–2580, December 2000. URL: http://dx.doi.org/10.1096/fj.00-0072com, doi:10.1096/fj.00-0072com. This article has 115 citations.](https://doi.org/10.1096/fj.00-0072com)

[8. (Kanaide2006Desensitization) Masato Kanaide, Yasuhito Uezono, Masanori Matsumoto, Minoru Hojo, Yuko Ando, Yuka Sudo, Koji Sumikawa, and Kohtaro Taniyama. Desensitization of gabab receptor signaling by formation of protein complexes of gabab2 subunit with grk4 or grk5. Journal of Cellular Physiology, 210(1):237–245, September 2006. URL: http://dx.doi.org/10.1002/jcp.20863, doi:10.1002/jcp.20863. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.20863)

[9. (Felder2002G) Robin A. Felder, Hironobu Sanada, Jing Xu, Pei-Ying Yu, Zheng Wang, Hidetsuna Watanabe, Laureano D. Asico, Wei Wang, Shaopeng Zheng, Ikuyo Yamaguchi, Scott M. Williams, James Gainer, Nancy J. Brown, Debra Hazen-Martin, Lee-Jun C. Wong, Jean E. Robillard, Robert M. Carey, Gilbert M. Eisner, and Pedro A. Jose. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proceedings of the National Academy of Sciences, 99(6):3872–3877, March 2002. URL: http://dx.doi.org/10.1073/pnas.062694599, doi:10.1073/pnas.062694599. This article has 225 citations.](https://doi.org/10.1073/pnas.062694599)